Now I have sufficient information to anchor my score. Let me compile all findings and write the consolidated review.

## Calibration Summary

**Round 1 — Bracketing:**
- Weak anchor band (<3.5): ProtFunAgent (3.00), Cell2Text (3.50), "Bridging Gene Expression" (3.50)
- Middle band (3.5-7.5): CellAgent (4.00), SC-Arena (5.00), CP-Agent (4.67)
- Strong band (>7.5): Not topically relevant

**Initial bracket: 3.0 – 5.0**

**Round 2 — Narrowing:**
Examined in full:
- CellAgent (4.00, Accept Poster): Similar domain. Had practical working system with 60+ datasets but limited novelty beyond tool orchestration.
- ProtFunAgent (3.00, Withdrawn/Reject): LLM agent for GO-like annotation. Rejected for trivial designs and weak baselines.
- Cell2Text (3.50, Reject): Single-cell + LLM descriptions. Rejected for insufficient validation.
- "Bridging Gene Expression and Text" (3.50, Reject): Rejected for flawed comparisons.
- CP-Agent (4.67, Accept Poster): Better validated multimodal approach.
- SC-Arena (5.00, Accept Poster): Well-validated benchmark.
- "Protein as a Second Language" (4.00, Reject): Good idea but rejected with concerns about validation.

**Comparative positioning:** HYPOGENEAGENT has a more novel conceptual contribution (closed-loop resolution selection) than CellAgent (tool orchestration) but weaker validation — only one dataset, no ground-truth comparison for the central claim. It's stronger than ProtFunAgent (3.00) and Cell2Text (3.50) but not as well-validated as CellAgent (4.00). The novelty and Stage 1 ablation are real strengths, but the core validation gap for the Resolution Score is substantial.

**Final score: 3.5**

Now writing the review.

---

Here is the consolidated review:

## Summary

HYPOGENEAGENT proposes an LLM-driven framework that closes the loop between clustering and functional annotation: it uses an LLM (GPT-o3) to generate ranked GO hypotheses for each cluster, computes intra-cluster agreement (ICS) and inter-cluster distinctiveness (ICD) from those hypotheses, and combines them into a Resolution Score to select the clustering granularity. The paper includes a thorough Stage 1 ablation on curated GOBP gene sets comparing embedding methods, prompt designs, temperatures, and LLM backends, and applies the best configuration to a K562 Perturb-seq dataset for resolution selection at both gene-expression and perturbation levels.

## Strengths

1. **Novel closed-loop framework linking resolution selection with functional annotation.** The paper introduces a genuinely new idea: using LLM-generated functional annotation consistency as a criterion for selecting clustering resolution. As the authors correctly note, existing systems act after clusters are fixed — HYPOGENEAGENT is the first to feed functional feedback back into the clustering hyperparameter search (Section 3.4). This conceptual contribution is significant and timely for the single-cell community.

2. **Thorough and systematic Stage 1 ablation on curated GOBP gene sets.** The paper compares three embedding methods (OpenAI, SapBERT, Nomic), two prompt classes with multiple versions, temperature values, five LLM backends (GPT-4o, GPT-o3, GPT-5, Gemini-2.0-flash, Gemini-2.5-pro), and validates that (a) thinking LLMs outperform non-thinking ones, (b) GPT-o3 with the hypothesis prompt achieves the highest cosine similarity (AUC=0.743), and (c) the model's confidence scores correlate with semantic similarity (Figure S3a, Section 4.3). This provides rigorous configuration selection before deployment on Perturb-seq data.

3. **Introduction of multiple ranked GO hypotheses with calibrated confidence scores enables the ICS/ICD framework.** The hypothesis prompt design (up to five ranked candidates with confidence scores, Section 3.3) is well-motivated and enables computing intra-cluster agreement as the similarity between the top hypothesis and lower-ranked ones. The Stage 1 validation showing the top-1 candidate group has the highest median cosine similarity with ground truth (Figure S1d) confirms the utility of the ranking.

4. **Application at two levels of granularity (gene-expression and perturbation).** The method is applied to both GEX and perturbation-level clusters on the same dataset (Figures 3 and 4), with both converging on biologically plausible resolutions (0.4 and 0.5), demonstrating the framework's generalizability to different input representations.

## Weaknesses

### Fatal
None.

### Major

1. **The Resolution Score is not validated against external biological ground truth on Perturb-seq data.** The paper's central claim is that the Resolution Score selects "biologically meaningful" clusterings that "recover known perturbation effects better than modularity and silhouette criteria" (Section 1). However, the evaluation never compares the chosen resolution against a known correct partition. The K562 Perturb-seq data (Replogle et al. 2022) carries ground truth: each guide targets a specific gene and guides targeting shared pathways should co-cluster at a meaningful resolution. The paper could evaluate whether clusters at the HYPOGENEAGENT-selected resolution recover known perturbation categories (e.g., pathways, protein complexes) better than resolutions chosen by silhouette or modularity using adjusted Rand index or normalized mutual information. Instead, the "validation" consists of (a) visual inspection of UMAP (Figures 3b, 4b) — inherently subjective — and (b) a functional enrichment analysis (Section 4.4.3, Figure 6) that itself depends on the same data and whose results are contradictory with the claimed resolution (see below). Without a quantitative benchmark against an external standard, the superiority claim is **unsubstantiated**.

2. **The Resolution Score measures LLM self-consistency, not biological accuracy.** ICS and ICD are computed entirely from the LLM's own outputs: ICS measures how similar the LLM's five hypotheses are for a single cluster, and ICD measures how different the top hypotheses are across clusters. A cluster that is biologically spurious but receives very consistent (and identically wrong) annotations from the LLM would achieve a high ICS. While Stage 1 validates the LLM's accuracy on curated GOBP sets (AUC=0.743), there is no evidence that the *self-consistency* measured by ICS/ICD correlates with biological coherence on the Perturb-seq data. The Resolution Score is therefore a proxy of unknown validity. This is an evidential gap in the paper's core evaluation design.

3. **Section 4.4.3 (functional enrichment comparison) is confusing and contradicts the paper's own conclusions.** The text describes applying "similar metrics" to GO enrichment results, but never explains how overrepresentation p-values are converted to the ICS/ICD framework. Figure 6a clearly shows the Resolution Score peaking at resolution 0.7. Despite this, the text states "the selected resolution can be 0.5 or 0.4, which is consistent with our previous selection." This is a direct contradiction — the enrichment-based score peaks at 0.7, not 0.4–0.5 — and the paper does not reconcile this discrepancy. The reasoning here is muddy and undermines the otherwise clear presentation.

4. **The comparison with traditional metrics (silhouette, modularity) lacks an independent adjudicator.** The paper shows that silhouette peaks at resolution 0.5–0.6, modularity at 0.7, and HYPOGENEAGENT at 0.4–0.5. It then discusses known limitations of these metrics (convex geometry assumption, insensitivity to small clusters) and asserts that HYPOGENEAGENT's choice is better because it yields "functional coherence." But functional coherence is measured using the same HYPOGENEAGENT pipeline — there is no independent arbiter. The paper never tests whether the HYPOGENEAGENT-chosen resolution actually improves downstream biological discovery (e.g., better separation of known perturbation classes) relative to the resolutions chosen by silhouette or modularity. A simple baseline would be asking: does a standard GO enrichment analysis on clusters at resolution 0.4 produce more significant or more specific enrichments than at resolution 0.7?

### Minor

5. **Weight selection (w=1/3) is under-explored.** The paper states w=1/3 was chosen by a "small grid search" on the same K562 dataset, without cross-validation or reporting the grid range. Supplementary Figure S5 shows the Resolution Score's dependence on w varies across clusters, yet no analysis of whether alternative w values would change the chosen resolution is provided. This weakens the claim that the scoring function is general.

6. **Stage 1 ablation conclusions may not fully transfer to Stage 2.** The GOBP benchmark uses curated gene sets that are well-defined and typically short (<50 genes). Real single-cell cluster signatures are often larger and noisier. While not a fatal issue, the paper does not discuss whether the optimal configuration from Stage 1 (e.g., GPT-o3 + hypothesis prompt) would remain optimal on noisier, larger input gene lists.

### Trivial
None.

## Nice-to-Haves

- Report the stability of the Resolution Score across multiple independent LLM runs (e.g., 5–10 repeats with different seeds).
- Clarify what "small grid search" means for the weight w: report the grid range, the criterion used, and ideally perform leave-one-resolution-out validation.
- Explicitly clarify in the main text that S_k^cos (Table 1) is only used for the Stage 1 GOBP benchmark, not for the Resolution Score.

## Removed Points

These points were identified by the reviewers but are removed or downgraded here:

- **"Resolution Score optimizes for LLM behavior rather than biological truth"** — The Harsh Critic framed this as a "structural weakness." After verification, the Stage 1 validation (AUC=0.743 on GOBP sets) confirms the LLM produces reasonably accurate annotations. The criticism is better framed as an evidential gap (weakness 2 above), not a structural flaw. Demoted from what could be read as fatal to Major.

- **"No code release / reproducibility concerns"** — The paper states code and prompt templates are in the appendix. Since the parser strips appendices, this is not verifiable and the existence of code is presumed. Removed.

- **"Missing related work"** — Cannot be externally verified. Removed by rule.

- **"Self-referential metrics may be circular"** — The Strength Finder claimed evidence of "quantitative evidence that the agent-derived Resolution Score selects biologically meaningful granularities outperforming classical metrics." After verification, this strength conflicts with verified weaknesses (no ground truth, self-referential metrics). Removed.

- **"Comprehensive comparison with three traditional benchmarks"** — The comparison is presented but quality is undermined by the confusing Section 4.4.3 and lack of independent adjudicator. Downgraded from a claimed strength.

## Novel Insights

None beyond the paper's own contributions. The novel insight — that LLM annotation consistency can serve as a resolution selection criterion — is the paper's own contribution, not one that emerges from the reviews.

## Suggestions

1. **Add ground-truth validation on Perturb-seq**: The Replogle et al. dataset has known perturbation targets (guides targeting genes in shared pathways and complexes). Define a ground-truth grouping (e.g., guides targeting the same pathway should co-cluster) and measure how well each candidate resolution recovers this grouping via adjusted Rand index or NMI. Show that the Resolution Score selects the resolution maximizing this recovery, and that this resolution outperforms those selected by silhouette and modularity.

2. **Clarify or restructure Section 4.4.3**: The functional enrichment analysis currently produces contradictory results (peak at 0.7 vs. claimed 0.4–0.5). Either explain the discrepancy rigorously, or remove this comparison if it cannot be reconciled. If retained, explain exactly how ICS/ICD are computed from GO p-values.

3. **Include a simple GO enrichment baseline**: Compare HYPOGENEAGENT's Resolution Score against a baseline that selects the resolution maximizing the average -log10 adjusted p-value across clusters (or similar). This would provide a more convincing biology-aware comparison than the current presentation.

4. **Validate weight robustness**: Report the grid search range for w, and show that the selected resolution is stable across a range of w values (e.g., 0.2–0.5) rather than only at w=1/3.

5. **Report variance across LLM runs**: Show that the Resolution Score is stable across multiple independent runs of the LLM (which is stochastic). This addresses concerns about sensitivity to sampling randomness.

## Score and Decision

**Calibration anchors used:**

| Paper | Avg Score | Round | Comparison |
|-------|-----------|-------|------------|
| CellAgent (single-cell agent) | 4.00 | R1, R2 | More practical validation (60+ datasets), similar domain, accepted poster |
| ProtFunAgent (GO annotation agent) | 3.00 | R1, R2 | Similar GO/LLM methodology, rejected — our paper is more novel |
| Cell2Text (single-cell LLM) | 3.50 | R1, R2 | Similar validation level, rejected |
| Bridging Gene Expression and Text | 3.50 | R1, R2 | Similar validation level, rejected |
| SC-Arena (single-cell benchmark) | 5.00 | R1, R2 | Better validated, accepted poster |
| CP-Agent (cell painting agent) | 4.67 | R1, R2 | Better validated, accepted poster |
| Protein as Second Language | 4.00 | R2 | Good idea but insufficient validation, rejected |

**Round 1 bracket**: 3.0 – 5.0 (weakest anchor ProtFunAgent at 3.0, mid anchor CellAgent at 4.0, strong end anchor SC-Arena at 5.0)

**Round 2 narrowing**: The paper is clearly stronger than ProtFunAgent (3.00) — more novel framework, better ablation. It is comparable in overall quality to Cell2Text (3.50) and "Bridining Gene Expression" (3.50) — interesting idea with a key validation gap. It is weaker than CellAgent (4.00) which, despite limited novelty, provided practical validation on 60+ datasets. The core validation gap (no ground truth, confusing Section 4.4.3) prevents the paper from reaching the CellAgent/CP-Agent level.

**Final score: 3.5.** The paper introduces a genuinely novel framework and includes a thorough Stage 1 ablation. However, the central claim about the Resolution Score's biological superiority lacks proper validation against ground truth, and Section 4.4.3 contains a confusing contradiction. These are evidential gaps that could be addressed with additional experiments, but as presented, the evidence does not convincingly support the paper's strongest claims.

**Decision: Reject.**

MY FINAL SCORE: <score>3.5</score>
MY FINAL DECISION: <decision>Reject</decision>